Results from a clinical trial of a novel aldosterone synthase inhibitor, lorundrostat, found it significantly reduces ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

The FDA has updated labels on the top two COVID-19 vaccines to warn of a rare heart side effect, mostly seen in young men.

Since 1970, heart attack deaths have fallen almost 90 per cent in the US, though deaths from chronic heart conditions have ...

Obesity remains one of the greatest health challenges worldwide, leading to diabetes, heart disease, and increased healthcare ...

The Food and Drug Administration said Wednesday it was expanded existing warnings on the two leading COVID vaccines about a ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

The American College of Cardiology has issued new guidelines recommending weight management medications as first-line treatments for eligible patients. This contrasts with prior guidelines that ...

With the FDA recently rejecting a drug application that aims to help those living with Barth Syndrome, one Bay Area family is ...

Older adults may benefit from a recently introduced tool that assesses their risk for heart disease, according to a new study ...